Occam’s Board Practice Continues to Flourish
Occam Global placed Josh Ofman, MD, as Chairman of the Board of EveryONE Medicines in July 2024. The company was founded with seed financing from Khosla Ventures, GV, and Third Rock Ventures to develop treatments tailored to individual patients with ultra-orphan diseases.
Ofman is the President of GRAIL, a publicly-traded Illumina spinout backed by ARCH Venture Partners, Bezos Expeditions, Bill Gates, and Sutter Hill Ventures. He spent more than 15 years at Amgen, where he most recently held the role of Senior Vice President, Global Value, Access, and Policy.
Josh holds a BA in history and philosophy of science from the University of California, Berkeley, and an MD from theUniversity of California, Irvine, School of Medicine.
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.